A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Annexon, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 5,989,017 shares of ANNX stock, worth $43.6 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
5,989,017
Previous 5,989,017 -0.0%
Holding current value
$43.6 Million
Previous $29.3 Million -0.0%
% of portfolio
0.08%
Previous 0.08%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.33 - $6.79 $3.61 Million - $5.65 Million
832,617 Added 16.15%
5,989,017 $29.3 Million
Q1 2024

May 15, 2024

BUY
$4.03 - $7.81 $20.8 Million - $40.3 Million
5,156,400 New
5,156,400 $37 Million
Q1 2023

May 15, 2023

SELL
$3.74 - $7.46 $1.08 Million - $2.15 Million
-288,716 Reduced 38.5%
461,284 $1.78 Million
Q4 2022

Feb 14, 2023

BUY
$4.56 - $6.61 $3.42 Million - $4.96 Million
750,000 New
750,000 $3.88 Million
Q1 2022

May 16, 2022

SELL
$2.73 - $11.94 $2.39 Million - $10.4 Million
-874,752 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$11.49 - $22.0 $1.7 Million - $3.25 Million
-147,731 Reduced 14.45%
874,752 $10.1 Million
Q3 2021

Nov 15, 2021

BUY
$16.35 - $23.4 $11 Million - $15.7 Million
671,371 Added 191.21%
1,022,483 $19 Million
Q2 2021

Aug 16, 2021

BUY
$17.81 - $27.48 $1.83 Million - $2.82 Million
102,618 Added 41.3%
351,112 $7.9 Million
Q1 2021

May 17, 2021

BUY
$22.0 - $35.01 $5.47 Million - $8.7 Million
248,494 New
248,494 $6.92 Million

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $347M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.